Total Payments
$28,653
2024 Payments
$3,935
Companies
55
Transactions
848
Medicare Patients
3,980
Medicare Billing
$794,126
Payment Breakdown by Category
Food & Beverage$28,137 (98.2%)
Education$260.11 (0.9%)
Consulting$133.75 (0.5%)
Other$121.63 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,137 | 828 | 98.2% |
| Education | $260.11 | 18 | 0.9% |
| Consulting Fee | $133.75 | 1 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $121.63 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $2,521 | 62 | $0 (2024) |
| ABBVIE INC. | $2,184 | 65 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,825 | 29 | $0 (2024) |
| EMD Serono, Inc. | $1,615 | 35 | $0 (2024) |
| UCB, Inc. | $1,566 | 51 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,464 | 85 | $0 (2024) |
| Allergan, Inc. | $1,312 | 41 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $1,177 | 30 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,155 | 32 | $0 (2024) |
| SK Life Science, Inc. | $1,131 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,935 | 126 | UCB, Inc. ($640.91) |
| 2023 | $5,088 | 182 | AbbVie Inc. ($811.15) |
| 2022 | $4,139 | 139 | Novartis Pharmaceuticals Corporation ($459.51) |
| 2021 | $2,962 | 96 | AbbVie Inc. ($309.43) |
| 2020 | $1,871 | 66 | Allergan, Inc. ($460.48) |
| 2019 | $3,181 | 64 | Biogen, Inc. ($875.02) |
| 2018 | $3,560 | 87 | Biogen, Inc. ($526.24) |
| 2017 | $3,917 | 88 | Sunovion Pharmaceuticals Inc. ($601.36) |
All Payment Transactions
848 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Neuropsychiatry | ||||||
| 12/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.39 | General |
| Category: Narcoplepsy | ||||||
| 12/10/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: AMANTADINE | ||||||
| 12/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $45.89 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Neurology | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: PAIN | ||||||
| 11/13/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Neurology | ||||||
| 11/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: AMANTADINE | ||||||
| 11/06/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: AMANTADINE | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Neuropsychiatry | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $38.33 | General |
| Category: Neurology | ||||||
| 10/22/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $122.07 | General |
| Category: Neurology | ||||||
| 10/12/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $20.49 | General |
| 10/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Neuropsychiatry | ||||||
| 09/27/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 09/25/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $120.96 | General |
| Category: Immunology | ||||||
| 09/23/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Neurology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Neurology | ||||||
| 09/20/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $8.85 | General |
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PAIN | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 995 | 1,901 | $328,755 | $203,778 |
| 2022 | 5 | 999 | 1,765 | $318,215 | $194,281 |
| 2021 | 5 | 980 | 1,812 | $318,310 | $197,292 |
| 2020 | 5 | 1,006 | 1,829 | $316,610 | $198,775 |
Total Patients
3,980
Total Services
7,307
Medicare Billing
$794,126
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 245 | 764 | $99,320 | $76,163 | 76.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 365 | 385 | $125,125 | $55,941 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 586 | $70,290 | $51,370 | 73.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 141 | 141 | $31,020 | $19,118 | 61.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 19 | 25 | $3,000 | $1,186 | 39.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 408 | 437 | $142,025 | $72,750 | 51.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 262 | 673 | $87,490 | $58,251 | 66.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 534 | $64,080 | $48,003 | 74.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 101 | 101 | $22,220 | $14,294 | 64.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 18 | 20 | $2,400 | $982.97 | 41.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 410 | 432 | $140,400 | $74,010 | 52.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 274 | 732 | $95,160 | $64,680 | 68.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 201 | 548 | $64,650 | $48,068 | 74.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 61 | 61 | $13,420 | $8,583 | 64.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 34 | 39 | $4,680 | $1,951 | 41.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 391 | 414 | $134,550 | $72,337 | 53.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 248 | 689 | $89,570 | $62,079 | 69.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 227 | 583 | $64,130 | $47,472 | 74.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 112 | 112 | $24,640 | $15,316 | 62.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 28 | 31 | $3,720 | $1,571 | 42.2% |
About Dr. Nancy Vu, M.D
Dr. Nancy Vu, M.D is a Neurology healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821059957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Vu, M.D has received a total of $28,653 in payments from pharmaceutical and medical device companies, with $3,935 received in 2024. These payments were reported across 848 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($28,137).
As a Medicare-enrolled provider, Vu has provided services to 3,980 Medicare beneficiaries, totaling 7,307 services with total Medicare billing of $794,126. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fountain Valley, CA
- Active Since 03/29/2006
- Last Updated 05/01/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821059957
Products in Payments
- INGREZZA (Drug) $1,383
- APTIOM (Drug) $1,334
- KESIMPTA (Drug) $1,307
- UBRELVY (Drug) $1,179
- Briviact (Drug) $1,029
- Fycompa (Drug) $823.35
- TYSABRI (Biological) $802.88
- Aimovig (Biological) $793.22
- VRAYLAR (Drug) $729.86
- QULIPTA (Drug) $708.79
- AUSTEDO (Drug) $687.06
- NUEDEXTA (Drug) $647.95
- EMGALITY (Drug) $598.18
- REXULTI (Drug) $591.93
- TECFIDERA (Drug) $590.10
- Gamunex-C (Biological) $565.38
- NURTEC ODT (Drug) $554.28
- ULTOMIRIS (Biological) $493.78
- Mavenclad (Drug) $484.71
- GOCOVRI (Drug) $463.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fountain Valley
Dr. Daniel Truong, M.d, M.D
Neurology — Payments: $198,412
Neurology $198,412
Kong Truong, M.d, M.D
Neurology — Payments: $30,261
Neurology $30,261
Deepmala Nandanwar, M.d, M.D
Neurology — Payments: $24,211
Neurology $24,211
Frank Xing
Neurology — Payments: $19,618
Neurology $19,618
Dr. Mehrdad Mahdad, M.d, M.D
Neurology — Payments: $12,845
Neurology $12,845
Duke Phan, Md, MD
Neurology — Payments: $3,793
Neurology $3,793